Discontinuation report ZOLEDRONIC ACID INJECTION
| Report ID | 14030 |
| Drug Identification Number | 02408082 |
| Brand name | ZOLEDRONIC ACID INJECTION |
| Common or Proper name | ZOLEDRONIC ACID |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100ML |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-03-03 |
| Remaining supply date | 2017-03-03 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-06-27 | English | Compare |
| v2 | 2017-06-27 | French | Compare |
Showing 1 to 2 of 2